vs
Side-by-side financial comparison of Elme Communities (ELME) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $62.1M, roughly 2.0× Elme Communities). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -198.9%, a 202.2% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 1.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $7.2M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 2.7%).
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
ELME vs NATR — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $123.8M |
| Net Profit | $-123.5M | $4.1M |
| Gross Margin | 61.1% | 72.5% |
| Operating Margin | -183.3% | 4.3% |
| Net Margin | -198.9% | 3.3% |
| Revenue YoY | 1.7% | 4.7% |
| Net Profit YoY | -4058.7% | 1379.4% |
| EPS (diluted) | $-1.40 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $123.8M | ||
| Q3 25 | $62.1M | $128.3M | ||
| Q2 25 | $62.1M | $114.8M | ||
| Q1 25 | $61.5M | $113.2M | ||
| Q4 24 | $61.3M | $118.2M | ||
| Q3 24 | $61.1M | $114.6M | ||
| Q2 24 | $60.1M | $110.6M | ||
| Q1 24 | $59.5M | $111.0M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | $-123.5M | $5.3M | ||
| Q2 25 | $-3.6M | $5.3M | ||
| Q1 25 | $-4.7M | $4.7M | ||
| Q4 24 | $-3.0M | $-321.0K | ||
| Q3 24 | $-3.0M | $4.3M | ||
| Q2 24 | $-3.5M | $1.3M | ||
| Q1 24 | $-3.6M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | 61.1% | 73.3% | ||
| Q2 25 | 63.5% | 71.7% | ||
| Q1 25 | 64.2% | 72.1% | ||
| Q4 24 | 62.9% | 72.0% | ||
| Q3 24 | 63.5% | 71.3% | ||
| Q2 24 | 63.4% | 71.4% | ||
| Q1 24 | 63.5% | 71.2% |
| Q4 25 | — | 4.3% | ||
| Q3 25 | -183.3% | 7.0% | ||
| Q2 25 | 9.6% | 3.7% | ||
| Q1 25 | 7.8% | 5.4% | ||
| Q4 24 | 10.4% | 3.8% | ||
| Q3 24 | 11.0% | 4.6% | ||
| Q2 24 | 9.8% | 5.1% | ||
| Q1 24 | 7.5% | 4.2% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | -198.9% | 4.2% | ||
| Q2 25 | -5.7% | 4.6% | ||
| Q1 25 | -7.6% | 4.2% | ||
| Q4 24 | -4.9% | -0.3% | ||
| Q3 24 | -4.9% | 3.8% | ||
| Q2 24 | -5.8% | 1.2% | ||
| Q1 24 | -6.1% | 2.1% |
| Q4 25 | — | $0.23 | ||
| Q3 25 | $-1.40 | $0.30 | ||
| Q2 25 | $-0.04 | $0.28 | ||
| Q1 25 | $-0.05 | $0.25 | ||
| Q4 24 | $-0.04 | $-0.02 | ||
| Q3 24 | $-0.03 | $0.23 | ||
| Q2 24 | $-0.04 | $0.07 | ||
| Q1 24 | $-0.04 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $908.9M | $161.6M |
| Total Assets | $1.7B | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $93.9M | ||
| Q3 25 | $7.1M | $95.6M | ||
| Q2 25 | $4.8M | $81.3M | ||
| Q1 25 | $6.4M | $86.5M | ||
| Q4 24 | $6.1M | $84.7M | ||
| Q3 24 | $4.8M | $78.7M | ||
| Q2 24 | $5.6M | $68.7M | ||
| Q1 24 | $4.2M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
| Q4 25 | — | $161.6M | ||
| Q3 25 | $908.9M | $166.7M | ||
| Q2 25 | $1.0B | $163.7M | ||
| Q1 25 | $1.1B | $167.1M | ||
| Q4 24 | $1.1B | $161.0M | ||
| Q3 24 | $1.1B | $162.6M | ||
| Q2 24 | $1.1B | $156.4M | ||
| Q1 24 | $1.1B | $159.7M |
| Q4 25 | — | $261.1M | ||
| Q3 25 | $1.7B | $264.8M | ||
| Q2 25 | $1.8B | $254.9M | ||
| Q1 25 | $1.8B | $252.7M | ||
| Q4 24 | $1.8B | $240.9M | ||
| Q3 24 | $1.9B | $245.3M | ||
| Q2 24 | $1.9B | $235.8M | ||
| Q1 24 | $1.9B | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.9M | $9.9M |
| Free Cash FlowOCF − Capex | $7.2M | $7.6M |
| FCF MarginFCF / Revenue | 11.6% | 6.1% |
| Capex IntensityCapex / Revenue | 14.0% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $86.7M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $9.9M | ||
| Q3 25 | $15.9M | $18.5M | ||
| Q2 25 | $29.8M | $4.3M | ||
| Q1 25 | $16.2M | $2.6M | ||
| Q4 24 | $95.2M | $12.2M | ||
| Q3 24 | $20.7M | $9.6M | ||
| Q2 24 | $28.9M | $1.3M | ||
| Q1 24 | $21.2M | $2.2M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | $7.2M | $16.8M | ||
| Q2 25 | $21.1M | $3.0M | ||
| Q1 25 | $10.5M | $1.5M | ||
| Q4 24 | $47.9M | $10.0M | ||
| Q3 24 | $8.8M | $7.9M | ||
| Q2 24 | $21.0M | $-2.0M | ||
| Q1 24 | $7.6M | $-1.5M |
| Q4 25 | — | 6.1% | ||
| Q3 25 | 11.6% | 13.1% | ||
| Q2 25 | 34.1% | 2.6% | ||
| Q1 25 | 17.1% | 1.3% | ||
| Q4 24 | 78.1% | 8.5% | ||
| Q3 24 | 14.4% | 6.9% | ||
| Q2 24 | 34.9% | -1.9% | ||
| Q1 24 | 12.8% | -1.4% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | 14.0% | 1.3% | ||
| Q2 25 | 14.0% | 1.2% | ||
| Q1 25 | 9.2% | 1.0% | ||
| Q4 24 | 77.4% | 1.9% | ||
| Q3 24 | 19.4% | 1.5% | ||
| Q2 24 | 13.1% | 3.0% | ||
| Q1 24 | 22.9% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
